These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 7930557)

  • 1. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
    Li M; Martin A; Liu DT; Whitworth JA
    J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary chloride does not correlate with urinary thromboxane in deoxycorticosterone acetate-treated rats.
    Theriot JA; Passmore JC; Jimenez AE; Fleming JT
    J Lab Clin Med; 2000 Jun; 135(6):493-7. PubMed ID: 10850649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volume sensitive hypertension and the digoxin-like factor. Reversal by a Fab directed against digoxin in DOCA-salt hypertensive rats.
    Krep H; Price DA; Soszynski P; Tao QF; Graves SW; Hollenberg NK
    Am J Hypertens; 1995 Sep; 8(9):921-7. PubMed ID: 8541008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of digoxin-like factor (DLF) and ADH during DOCA-salt and Goldblatt 2 kidney-1 clip hypertension development.
    Vargas F; Casanova I; Haro JM; Luna JD; Garcia del Rio C
    Horm Metab Res; 1990 Jun; 22(6):352-5. PubMed ID: 2199365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered regulation of renal sodium transporters and natriuretic peptide system in DOCA-salt hypertensive rats.
    Bae EH; Kim IJ; Ma SK; Kim SW
    Regul Pept; 2009 Oct; 157(1-3):76-83. PubMed ID: 19422859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of kidney damage by supplementation of vitamins C and E in rats with deoxycorticosterone-salt-induced hypertension.
    Seifi B; Kadkhodaee M; Karimian SM; Zahmatkesh M; Shams S; Bakhshi E
    Iran J Kidney Dis; 2009 Oct; 3(4):197-202. PubMed ID: 19841522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
    Suzuki H; Kondo K; Saruta T
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):525-32. PubMed ID: 7270008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium prevents saline deoxycorticosterone acetate (DOCA) hypertension in the rat.
    Iaina A; Shochat J; Serban I; Kapuler S; Gavendo S; Goldfarb D; Eliahou HE
    J Lab Clin Med; 1982 Feb; 99(2):231-8. PubMed ID: 6278037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A different role of digoxin-like factor in the maintenance of elevated blood pressure in rats treated with DOCA and saline in youth or only in adulthood.
    Zicha J; Stolba P; Pohlová I; Kunes J; Jelínek J
    J Hypertens Suppl; 1984 Dec; 2(3):S481-3. PubMed ID: 6599704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
    Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG
    Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of DOCA and salt intake on body sodium, fluid intake, blood pressure and excretion of a sodium load in rats.
    Simpson FO; Ledingham JM; Paulin JM; Purves RD
    J Hypertens Suppl; 1985 Dec; 3(3):S77-8. PubMed ID: 2856786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats.
    Robin S; Maupoil V; Laurant P; Jacqueson A; Berthelot A
    Br J Nutr; 2004 Jun; 91(6):857-65. PubMed ID: 15182389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-, potassium-, chloride-, and bicarbonate-related effects on blood pressure and electrolyte homeostasis in deoxycorticosterone acetate-treated rats.
    Ziomber A; Machnik A; Dahlmann A; Dietsch P; Beck FX; Wagner H; Hilgers KF; Luft FC; Eckardt KU; Titze J
    Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1752-63. PubMed ID: 18842823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent DOCA-salt hypertension in Brattleboro rats: the role of vasopressin.
    Zicha J; Kunes J; Jelínek J
    Physiol Bohemoslov; 1987; 36(1):33-42. PubMed ID: 2954169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats.
    Jin L; Beswick RA; Yamamoto T; Palmer T; Taylor TA; Pollock JS; Pollock DM; Brands MW; Webb RC
    J Physiol Pharmacol; 2006 Sep; 57(3):343-57. PubMed ID: 17033089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of estrogen on serum nitric oxide concentrations in normotensive and DOCA Salt hypertensive ovariectomized rats.
    Nematbakhsh M; Khazaei M
    Clin Chim Acta; 2004 Jun; 344(1-2):53-7. PubMed ID: 15149870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
    Silambarasan T; Raja B
    Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DOCA stimulates salt appetite in Zucker rats: effect of dose, synergistic action with central angiotensin II, and obesity.
    Omouessi ST; Falconetti C; Fernette B; Thornton SN
    Brain Res Bull; 2007 Sep; 74(1-3):14-20. PubMed ID: 17683784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
    Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.